Browse by ["viewname_eprint_publisher" not defined]

B

Breyer, Johannes and Eckstein, Markus and Sikic, Danijel and Wezel, Felix and Roghmann, Florian and Brehmer, Mirco and Wirtz, Ralph M. and Jarczyk, Jonas and Erben, Philipp and Bahlinger, Veronika and Goldschmidt, Franziska and Fechner, Guido and Chen, Jack and Paxinos, Ellen and Bates, Michael and Haas, Maximilian and Zengerling, Friedemann and Bolenz, Christian and Burger, Maximilian and Hartmann, Arndt and Kriegmair, Maximilian C. (2023) Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial). SCIENTIFIC REPORTS, 13 (1): 15437. ISSN 2045-2322,

E

Eckstein, Markus and Kimmel, Charlotte and Bruendl, Johannes and Weber, Florian and Denzinger, Stefan and Gierth, Michael and Burger, Maximilian and Hartmann, Arndt and Otto, Wolfgang and Breyer, Johannes (2021) Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer. SCIENTIFIC REPORTS, 11 (1): 17981. ISSN 2045-2322,

H

Hartmann, Valerie and Engelmann, Simon Udo and Pickl, Christoph and Haas, Maximilian and Kaelble, Sebastian and Gossler, Christopher and Eckl, Christoph and Hofmann, Aybike and Pichler, Renate and Burger, Maximilian and Mayr, Roman (2024) Impact of sarcopenia and fat distribution on outcomes in penile cancer. SCIENTIFIC REPORTS, 14 (1): 25422. ISSN 2045-2322,

V

van Dorp, Jeroen and Pipinikas, Christodoulos and Suelmann, Britt B. M. and Mehra, Niven and van Dijk, Nick and Marsico, Giovanni and van Montfoort, Maurits L. and Hackinger, Sophie and Braaf, Linde M. and Amarante, Tauanne and van Steenis, Charlaine and McLay, Kirsten and Daletzakis, Antonios and van den Broek, Daan and van de Kamp, Maaike W. and Hendricksen, Kees and de Feijter, Jeantine M. and Boellaard, Thierry N. and Meijer, Richard P. and van der Heijden, Toine G. and Rosenfeld, Nitzan and van Rhijn, Bas W. G. and Jones, Greg and van der Heijden, Michiel S. (2023) High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial. NATURE MEDICINE, 29 (3). 588-+. ISSN 1078-8956, 1546-170X